FDA advisers vote to include an Omicron-specific component for a coronavirus booster in the US
Get the Full StoryThe US Food and Drug Administration's independent Vaccines and Related Biological Products Advisory Committee VRBPAC voted Tuesday to support recommending inclusion of an Omicron specific component for a Covid-19 booster vaccine.Share: